Hematology in September 2026: ASH raises ferritin thresholds for iron deficiency, plus marstacimab in hemophilia and curative SCD care.
Advertisement
Advertisement
Hematology news in September 2026 included new diagnostic thresholds for iron deficiency, a closer look at the expanded approval of marstacimab in hemophilia A and B, and expert perspective on choosing between curative therapies in sickle cell disease.
The American Society of Hematology (ASH) raised the serum ferritin thresholds used to diagnose iron deficiency, a change that may identify patients who previously fell just above diagnostic cutoffs, including those...
At ACAAI 2026, Jennifer Priessnitz, MD presented data which found omalizumab had the highest anaphylaxis reporting proportion among 7 respiratory biologics.